Annual Revenue
$17.16 M
+$6.87 M+66.78%
December 31, 2023
Summary
- As of February 26, 2025, ANAB annual revenue is $17.16 million, with the most recent change of +$6.87 million (+66.78%) on December 31, 2023.
- During the last 3 years, ANAB annual revenue has fallen by -$57.84 million (-77.12%).
- ANAB annual revenue is now -77.12% below its all-time high of $75.00 million, reached on December 31, 2020.
Performance
ANAB Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$30.02 M
+$19.05 M+173.60%
September 1, 2024
Summary
- As of February 26, 2025, ANAB quarterly revenue is $30.02 million, with the most recent change of +$19.05 million (+173.60%) on September 1, 2024.
- Over the past year, ANAB quarterly revenue has stayed the same.
- ANAB quarterly revenue is now -49.97% below its all-time high of $60.00 million, reached on December 31, 2020.
Performance
ANAB Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$57.17 M
+$26.70 M+87.62%
September 1, 2024
Summary
- As of February 26, 2025, ANAB TTM revenue is $57.17 million, with the most recent change of +$26.70 million (+87.62%) on September 1, 2024.
- Over the past year, ANAB TTM revenue has stayed the same.
- ANAB TTM revenue is now -53.20% below its all-time high of $122.16 million, reached on September 30, 2021.
Performance
ANAB TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ANAB Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +66.8% | 0.0% | 0.0% |
| 3 y3 years | -77.1% | +43.7% | -53.2% |
| 5 y5 years | +243.1% | - | +614.6% |
ANAB Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -72.8% | +66.8% | at high | +2994.5% | -9.5% | +1173.3% |
| 5 y | 5-year | -77.1% | +114.5% | -50.0% | +2994.5% | -53.2% | +1173.3% |
| alltime | all time | -77.1% | +243.1% | -50.0% | +2994.5% | -53.2% | +1173.3% |
AnaptysBio Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $30.02 M(+173.6%) | $57.17 M(+87.6%) |
| Jun 2024 | - | $10.97 M(+52.8%) | $30.47 M(+32.7%) |
| Mar 2024 | - | $7.18 M(-20.3%) | $22.96 M(+33.8%) |
| Dec 2023 | $17.16 M(+66.8%) | $9.01 M(+171.4%) | $17.16 M(+14.7%) |
| Sep 2023 | - | $3.32 M(-4.1%) | $14.96 M(+15.7%) |
| Jun 2023 | - | $3.46 M(+151.8%) | $12.94 M(+21.0%) |
| Mar 2023 | - | $1.37 M(-79.8%) | $10.69 M(+3.9%) |
| Dec 2022 | $10.29 M(-83.7%) | $6.81 M(+426.5%) | $10.29 M(+129.1%) |
| Sep 2022 | - | $1.29 M(+6.3%) | $4.49 M(-81.4%) |
| Jun 2022 | - | $1.22 M(+25.4%) | $24.09 M(-54.5%) |
| Mar 2022 | - | $970.00 K(-4.1%) | $52.90 M(-16.3%) |
| Dec 2021 | $63.17 M(-15.8%) | $1.01 M(-95.2%) | $63.17 M(-48.3%) |
| Sep 2021 | - | $20.89 M(-30.4%) | $122.16 M(+20.6%) |
| Jun 2021 | - | $30.03 M(+167.0%) | $101.27 M(+42.1%) |
| Mar 2021 | - | $11.25 M(-81.3%) | $71.25 M(-5.0%) |
| Dec 2020 | $75.00 M(+837.5%) | $60.00 M(+300.0%) | $75.00 M(+226.1%) |
| Mar 2020 | - | $15.00 M(+400.0%) | $23.00 M(+187.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $8.00 M(+60.0%) | $3.00 M(-40.0%) | $8.00 M(-20.0%) |
| Jun 2019 | - | $5.00 M(0.0%) | $10.00 M(+25.0%) |
| Dec 2018 | $5.00 M(-50.0%) | - | - |
| Sep 2018 | - | $5.00 M(+66.7%) | $8.00 M(-20.0%) |
| Dec 2017 | $10.00 M(-40.1%) | $3.00 M(-57.1%) | $10.00 M(-22.9%) |
| Jun 2017 | - | $7.00 M(+154.2%) | $12.97 M(-22.3%) |
| Dec 2016 | $16.68 M(-5.0%) | $2.75 M(-14.3%) | $16.68 M(-7.2%) |
| Sep 2016 | - | $3.21 M(-45.1%) | $17.98 M(-6.9%) |
| Jun 2016 | - | $5.85 M(+20.2%) | $19.31 M(+5.3%) |
| Mar 2016 | - | $4.87 M(+20.0%) | $18.34 M(+4.4%) |
| Dec 2015 | $17.57 M(+10.9%) | $4.05 M(-10.7%) | $17.57 M(+2.0%) |
| Sep 2015 | - | $4.54 M(-7.0%) | $17.22 M(-8.6%) |
| Jun 2015 | - | $4.88 M(+19.2%) | $18.84 M(+35.0%) |
| Mar 2015 | - | $4.10 M(+10.6%) | $13.96 M(+41.6%) |
| Dec 2014 | $15.84 M(+188.9%) | $3.71 M(-39.8%) | $9.86 M(+60.2%) |
| Sep 2014 | - | $6.15 M | $6.15 M |
| Dec 2013 | $5.48 M | - | - |
FAQ
- What is AnaptysBio annual revenue?
- What is the all time high annual revenue for AnaptysBio?
- What is AnaptysBio annual revenue year-on-year change?
- What is AnaptysBio quarterly revenue?
- What is the all time high quarterly revenue for AnaptysBio?
- What is AnaptysBio quarterly revenue year-on-year change?
- What is AnaptysBio TTM revenue?
- What is the all time high TTM revenue for AnaptysBio?
- What is AnaptysBio TTM revenue year-on-year change?
What is AnaptysBio annual revenue?
The current annual revenue of ANAB is $17.16 M
What is the all time high annual revenue for AnaptysBio?
AnaptysBio all-time high annual revenue is $75.00 M
What is AnaptysBio annual revenue year-on-year change?
Over the past year, ANAB annual revenue has changed by +$6.87 M (+66.78%)
What is AnaptysBio quarterly revenue?
The current quarterly revenue of ANAB is $30.02 M
What is the all time high quarterly revenue for AnaptysBio?
AnaptysBio all-time high quarterly revenue is $60.00 M
What is AnaptysBio quarterly revenue year-on-year change?
Over the past year, ANAB quarterly revenue has changed by $0.00 (0.00%)
What is AnaptysBio TTM revenue?
The current TTM revenue of ANAB is $57.17 M
What is the all time high TTM revenue for AnaptysBio?
AnaptysBio all-time high TTM revenue is $122.16 M
What is AnaptysBio TTM revenue year-on-year change?
Over the past year, ANAB TTM revenue has changed by $0.00 (0.00%)